These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10976648)

  • 1. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.
    Ehl C; Kölsch H; Ptok U; Jessen F; Schmitz S; Frahnert C; Schlösser R; Rao ML; Maier W; Heun R
    Int J Mol Med; 2003 Feb; 11(2):235-8. PubMed ID: 12525884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism.
    Grimaldi LM; Casadei VM; Ferri C; Veglia F; Licastro F; Annoni G; Biunno I; De Bellis G; Sorbi S; Mariani C; Canal N; Griffin WS; Franceschi M
    Ann Neurol; 2000 Mar; 47(3):361-5. PubMed ID: 10716256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
    Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta and interleukin-6 gene polymorphisms as risk factors for AD: a prospective study.
    Ravaglia G; Paola F; Maioli F; Martelli M; Montesi F; Bastagli L; Bianchin M; Chiappelli M; Tumini E; Bolondi L; Licastro F
    Exp Gerontol; 2006 Jan; 41(1):85-92. PubMed ID: 16297587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between alpha-1-antichymotrypsin polymorphism and Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
    Am J Med Genet; 2000 Apr; 91(5):355-8. PubMed ID: 10766998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
    Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
    Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia.
    Craig D; Hart DJ; McCool K; McIlroy SP; Passmore AP
    Ann Neurol; 2004 Jul; 56(1):121-4. PubMed ID: 15236409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of alpha1-antichymotrypsin polymorphism with cerebral amyloid angiopathy.
    Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H
    Ann Neurol; 1998 Jul; 44(1):129-31. PubMed ID: 9667601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
    Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
    Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in the alpha(1)-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations.
    Morgan K; Licastro F; Tilley L; Ritchie A; Morgan L; Pedrini S; Kalsheker N
    Hum Genet; 2001 Sep; 109(3):303-10. PubMed ID: 11702211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease.
    Wang X; DeKosky ST; Wisniewski S; Aston ; Kamboh MI
    Ann Neurol; 1998 Sep; 44(3):387-90. PubMed ID: 9749607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
    Ma SL; Tang NL; Lam LC; Chiu HF
    Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
    Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between α1-antichymotrypsin signal peptide -15A/T polymorphism and the risk of Alzheimer's disease: a meta-analysis.
    Guan F; Gu J; Hu F; Zhu Y; Wang W
    Mol Biol Rep; 2012 Jun; 39(6):6661-9. PubMed ID: 22294107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
    Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
    Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.
    Combarros O; Sánchez-Guerra M; Infante J; Llorca J; Berciano J
    J Neurol; 2002 Sep; 249(9):1242-5. PubMed ID: 12242547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.